In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients

Antimicrob Agents Chemother. 2004 Dec;48(12):4922-5. doi: 10.1128/AAC.48.12.4922-4925.2004.

Abstract

We performed in vitro antifungal checkerboard testing on 12 Aspergillus fumigatus clinical isolates (6 transplant recipients and 6 nontransplant patients) with three antifungal agents (amphotericin B, voriconazole, and caspofungin) and three immunosuppressants (FK506, cyclosporine, and rapamycin). We were not able to detect a difference in calcineurin inhibitor antifungal activity against isolates from transplant recipients and nontransplant patients.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amphotericin B / pharmacology
  • Antifungal Agents / pharmacology*
  • Aspergillosis / drug therapy*
  • Aspergillus fumigatus / drug effects*
  • Calcineurin Inhibitors
  • Caspofungin
  • Cyclosporine / pharmacology
  • Echinocandins
  • Humans
  • Immunosuppressive Agents / pharmacology*
  • Lipopeptides
  • Organ Transplantation*
  • Peptides, Cyclic / pharmacology
  • Pyrimidines / pharmacology
  • Tacrolimus / pharmacology
  • Triazoles / pharmacology
  • Voriconazole

Substances

  • Antifungal Agents
  • Calcineurin Inhibitors
  • Echinocandins
  • Immunosuppressive Agents
  • Lipopeptides
  • Peptides, Cyclic
  • Pyrimidines
  • Triazoles
  • Amphotericin B
  • Cyclosporine
  • Caspofungin
  • Voriconazole
  • Tacrolimus